The APOBEC-2 crystal structure and functional implications for the deaminase AID (original) (raw)
References
Pham, P., Bransteitter, R. & Goodman, M. F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry44, 2703–2715 (2005) ArticleCAS Google Scholar
Conticello, S. G., Thomas, C. J. F., Petersen-Mahrt, S. K. & Neuberger, M. S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol.22, 367–377 (2004) Article Google Scholar
Bransteitter, R., Sneeden, J. L., Allen, S., Pham, P. & Goodman, O. M. F. First AID (activation-induced cytidine deaminase) is needed to produce high affinity isotype-switched antibodies. J. Biol. Chem.281, 16833–16836 (2006) ArticleCAS Google Scholar
Chiu, Y. L. & Greene, W. C. Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol.27, 291–297 (2006) ArticleCAS Google Scholar
Cullen, B. R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol.80, 1067–1076 (2006) ArticleCAS Google Scholar
Franca, R., Spadari, S. & Maga, G. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism. Med. Sci. Monit.12, RA92–RA98 (2006) CASPubMed Google Scholar
Bonvin, M. et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology43, 1364–1374 (2006) ArticleCAS Google Scholar
Johansson, E., Mejlhede, N., Neuhard, J. & Larsen, S. Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 Å resolution. Biochemistry41, 2563–2570 (2002) ArticleCAS Google Scholar
Xie, K. et al. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. Proc. Natl Acad. Sci. USA101, 8114–8119 (2004) ArticleADSCAS Google Scholar
Teh, A. et al. The 1.48 Å resolution crystal structure of the homotetrameric cytidine deaminase from mouse. Biochemistry45, 7825–7833 (2006) ArticleCAS Google Scholar
Chung, S. J., Fromme, J. C. & Verdine, G. L. Structure of human cytidine deaminase bound to a potent inhibitor. J. Med. Chem.48, 658–660 (2005) ArticleCAS Google Scholar
Betts, L., Xiang, S., Short, S. A., Wolfenden, R. & Carter, C. W. Cytidine deaminase. The 2.3 Å crystal structure of an enzyme: transition-state analog complex. Curr. Biol.235, 635–656 (1994) CAS Google Scholar
Smith, A. A., Carlow, D. C., Wolfenden, R. & Short, S. A. Mutations affecting transition-state stabilization by residues coordinating zinc at the active site of cytidine deaminase. Biochemistry33, 6468–6474 (1994) ArticleCAS Google Scholar
Durandy, A., Peron, S. & Fischer, A. Hyper-IgM syndromes. Curr. Opin. Rheumatol.18, 369–376 (2006) ArticleCAS Google Scholar
Minegishi, Y. et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin. Immunol.97, 203–210 (2000) ArticleCAS Google Scholar
Anant, S. et al. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am. J. Cell Physiol.281, C1904–C1916 (2001) ArticleCAS Google Scholar
Jarmuz, A. et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics79, 285–296 (2002) ArticleCAS Google Scholar
Shindo, K. et al. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem.278, 44412–44416 (2003) ArticleCAS Google Scholar
Wiegand, H. L., Doehle, B. P., Bogerd, H. P. & Cullen, B. R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J.23, 2451–2458 (2004) ArticleCAS Google Scholar
Opi, S. et al. Monomeric APOBEC3G is catalytically active and has antiviral activity. J. Virol.80, 4673–4682 (2006) ArticleCAS Google Scholar
Navarro, F. et al. Complementary function of the two catalytic domains of APOBEC3G. Virology333, 374–386 (2005) ArticleCAS Google Scholar
Wang, J. et al. Identification of a specific domain required for dimerization of activation-induced cytidine deaminase. J. Biol. Chem. (in the press).
Teng, B. et al. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1): structure-function relationships of RNA editing and dimerization. J. Lipid Res.40, 623–635 (1999) CASPubMed Google Scholar
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol.276, 307–326 (1997) ArticleCAS Google Scholar
Terwilliger, T. C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr.55, 849–861 (1999) ArticleCAS Google Scholar
Schneider, T. R. & Sheldrick, G. M. Substructure solution with SHELXD. Acta Crystallogr.58, 1772–1779 (2002) Article Google Scholar
Terwilliger, T. C. Maximum-likelihood density modification. Acta Crystallogr.56, 965–972 (2000) CAS Google Scholar
Bransteitter, R., Pham, P., Scharff, M. D. & Goodman, M. F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl Acad. Sci. USA100, 4102–4107 (2003) ArticleADSCAS Google Scholar